Jack Allen
Stock Analyst at Baird
(3.7)
Main Sectors:
Top Industries:
19 Stocks
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
TSHA Taysha Gene Therapie... | Maintains: Outperform | 7 12 | 4.76 | 152.1% | 5 | Oct 2, 2025 | |
VOR Vor Biopharma | Maintains: Neutral | 5 20 | 37.46 | -46.61% | 4 | Jun 27, 2025 | |
FATE Fate Therapeutics | Maintains: Neutral | 5 4 | 1.21 | 230.58% | 2 | May 14, 2025 | |
ALLO Allogene Therapeutic... | Maintains: Outperform | 12 9 | 1.33 | 576.69% | 3 | May 14, 2025 | |
CARM CARISMA Therapeutics | Downgrades: Neutral | 10 1 | n/a | n/a | 3 | Dec 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 80 40 | 15.02 | 166.31% | 2 | Nov 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 77 106 | 85.07 | 24.6% | 5 | Nov 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 24 18 | 19.96 | -9.82% | 2 | Oct 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 180 180 | 18.1 | 894.48% | 9 | Sep 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 140 120 | n/a | n/a | 3 | Aug 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 8 | 2.04 | 292.16% | 1 | Jun 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 46 52 | 67.74 | -23.24% | 2 | May 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 84 | 34.21 | 145.54% | 1 | Oct 31, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 200 25 | n/a | n/a | 3 | Sep 26, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 21 6 | n/a | n/a | 2 | Aug 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 5 | 1.67 | 199.4% | 1 | Nov 2, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 9 | n/a | n/a | 1 | Sep 13, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 2 | May 18, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 6 9 | 4.86 | 85.19% | 1 | Oct 7, 2021 |